Přejít k hlavnímu obsahu
Obrázek záhlaví
User picture
Akademický titul: Pharm.D.
Telefon: +420 585632126
Skupiny: IMTM, LEM, PERSONÁL

O mně

Researcher experienced in the field of nuclear medicine/pharmacy with the main research interest in preparation and analysis of radiolabeled compounds for microPET/SPECT/MRI/CT imaging, biodistribution studies of radiolabeled compounds in vivo and studies of behavior of radiolabeled compounds in vitro. Published 32 scientific papers, >50 abstracts, >260 SCI citations, H-index 10.

Zbynek is the contact person and coordinator under umbrella of The UPOL-Bioimaging Facility (BF: https://imtm.cz/core-facilities/bioimaging-core-facility) for the purposes of MRI/PET imaging of small animals (mice, rats). This includes whole process from the initial contact with the client asking for an imaging study via plannig of particular imaging up to evaluation of obtained image data using dedicated software tools. In case of any interest for MRI and/or MRI/PET imaging do not hesitate to contant Zbynek. MRI enables high-resulution imaging of whole body and has an advantage in imaging soft tissues (brain, heart, tumors) over to CT. The combination of MRI and PET imaging is cutting edge technology in preclincal imaging merging the advantages of both modalities, where PET adds more functional information to MRI image (e.g. glucose metabolism, expression of tumor targets, etc.).

Journals

DVOŘÁKOVÁ BENDOVÁ, K., T. GROLL, B. NEUŽILOVÁ, K. KRASULOVÁ, Z. NOVÝ, F. REISSIG, K. STEIGER, M. BOXBERG, E. EPPARD, J. WUESTEMANN, M. HAJDÚCH, M. JESINGHAUS, J. SIMECEK, M. KREISSL, M. PETŘÍK, J. NOTNI
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression. European Journal of Nuclear Medicine and Molecular Imaging. 2025, 53(1), 607-618, ISSN: 1619-7070, PMID: 40540027,  PDF.
TROMMER, J., M. ULLRICH, F. REISSIG, S. BRUHLMANN, A. NITT-WEBER, Z. NOVÝ, K. HAJDUOVÁ, D. KURFÜRSTOVÁ, R. HENDRYCHOVÁ, J. BOUCHAL, M. PETŘÍK, C. NEUBER, W. SIHVER, S. STADLBAUER, J. PIETZSCH, M. KRELLER, K. KOPKA, C. MAMAT, K. ZARSCHSLER
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 31, ISSN: 2365-421X, PMID: 40536585,
ONDRAK FIALOVA, K., L. ONDRAK, M. VLK, J. KOZEMPEL, K. NOVAKOVA, Z. NOVÝ, K. HAJDUOVÁ, M. HAJDÚCH, M. PETŘÍK, M. PRUSZYNSKI, F. BRUCHERTSEIFER, A. MORGENSTERN
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 16, ISSN: 2365-421X, PMID: 40183827,  PDF.

Master mentorship

Floriánová Adéla

Preclinical testing of novel radiolabeled receptor-specific ligands for tumor imaging

Stav: Ongoing od 2025.

Vajdová Sarah

Preclinical testing of novel radiolabeled receptor-specific ligands for tumor imaging

Stav: Probíhající od 2025.

Bachelor mentorship

Kašková Veronika

Hydroxyapatite nanoparticles as a potential diagnostics of solid tumors

Stav: Graduated od 2018 do 2019.

Hajduová Katarína

Nanoparticles for detection of sentinel lymph nodes

Stav: Absolvoval od 2019 do 2021.

Beňko Adam

Choline derivatives as potential cancer diagnostics and therapeutics

Stav: Absolvoval od 2016 do 2019.

Volná místa

1 Molekulární a translační medicína
Projekt: Multimodal imaging methods for preclinical testing of new bioactive molecules
Vedoucí: Nový Zbyněk Ph.D.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 místo v prezenční formě studia
2 Other specializations
Projekt: Small animal imaging using microPET/SPECT/CT system in preclinical developement of potential drugs
Vedoucí: Nový Zbyněk Ph.D.
K dispozici: 1
Určeno pro: Bachelor training
Projekt: Radiolabelled tracers for cancer imaging and therapy
Vedoucí: Nový Zbyněk Ph.D.
K dispozici: 1
Určeno pro: Magisterské studium
Souhrn: -